Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter?

OBJECTIVES: Data on the factors that contribute to the antibody response to hepatitis B virus vaccination in peritoneal dialysis patients are scarce. The current study was conducted on a group of peritoneal dialysis patients to learn how the response to hepatitis B virus vaccination varies according...

Full description

Bibliographic Details
Main Authors: Erkan Dervisoglu, Melih Simsek, Ahmet Yilmaz
Format: Article
Language:English
Published: Faculdade de Medicina / USP 2011-01-01
Series:Clinics
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000900009
id doaj-4ad448dfc7d04bd58e1903bdff23f3c0
record_format Article
spelling doaj-4ad448dfc7d04bd58e1903bdff23f3c02020-11-25T00:56:06ZengFaculdade de Medicina / USPClinics1807-59321980-53222011-01-016691559156210.1590/S1807-59322011000900009Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter?Erkan DervisogluMelih SimsekAhmet YilmazOBJECTIVES: Data on the factors that contribute to the antibody response to hepatitis B virus vaccination in peritoneal dialysis patients are scarce. The current study was conducted on a group of peritoneal dialysis patients to learn how the response to hepatitis B virus vaccination varies according to the patient's clearance of urea normalized to total body water (Kt/V). METHODS: A convenience sample of 33 peritoneal dialysis patients (13 women and 20 men, with a mean age of 49¡12 years) was administered double doses (20 &#956;g IM in each deltoid muscle) of recombinant hepatitis B vaccine at 0, 1, 2, and 6 months. Response to immunization was measured at one to three months after the final dose of vaccine. The subjects were divided into groups according to the level of antibodies to hepatitis B surface antigen (anti-HBs), including non-responders ( < 10 IU/L), weak responders (10-100 IU/L), and good responders ( > 100 IU/L). RESULTS: Among non-responders, weak responders, and good responders, significant differences were found in age (54 ± 12 vs. 56 ± 9 vs. 45¡12 years, respectively; p = 0.049) and recombinant human erythropoietin use (20 vs. 29 vs. 76%, respectively; p = 0.016). No significant differences in weekly total Kt/V (p = 0.704), weekly peritoneal Kt/V (p = 0.064) and residual glomerular filtration rate (p = 0.355) were found across the three groups. CONCLUSIONS: Delivered clearance measured by weekly peritoneal Kt/V and total clearance measured by weekly total Kt/V did not predict the response to hepatitis B virus vaccination in patients on peritoneal dialysis.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000900009Continuous ambulatory peritoneal dialysisHepatitis B virusVaccinationDialysis adequacyKt/V
collection DOAJ
language English
format Article
sources DOAJ
author Erkan Dervisoglu
Melih Simsek
Ahmet Yilmaz
spellingShingle Erkan Dervisoglu
Melih Simsek
Ahmet Yilmaz
Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter?
Clinics
Continuous ambulatory peritoneal dialysis
Hepatitis B virus
Vaccination
Dialysis adequacy
Kt/V
author_facet Erkan Dervisoglu
Melih Simsek
Ahmet Yilmaz
author_sort Erkan Dervisoglu
title Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter?
title_short Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter?
title_full Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter?
title_fullStr Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter?
title_full_unstemmed Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter?
title_sort antibody response following hepatitis b vaccination in peritoneal dialysis patients: does normalized urea clearance matter?
publisher Faculdade de Medicina / USP
series Clinics
issn 1807-5932
1980-5322
publishDate 2011-01-01
description OBJECTIVES: Data on the factors that contribute to the antibody response to hepatitis B virus vaccination in peritoneal dialysis patients are scarce. The current study was conducted on a group of peritoneal dialysis patients to learn how the response to hepatitis B virus vaccination varies according to the patient's clearance of urea normalized to total body water (Kt/V). METHODS: A convenience sample of 33 peritoneal dialysis patients (13 women and 20 men, with a mean age of 49¡12 years) was administered double doses (20 &#956;g IM in each deltoid muscle) of recombinant hepatitis B vaccine at 0, 1, 2, and 6 months. Response to immunization was measured at one to three months after the final dose of vaccine. The subjects were divided into groups according to the level of antibodies to hepatitis B surface antigen (anti-HBs), including non-responders ( < 10 IU/L), weak responders (10-100 IU/L), and good responders ( > 100 IU/L). RESULTS: Among non-responders, weak responders, and good responders, significant differences were found in age (54 ± 12 vs. 56 ± 9 vs. 45¡12 years, respectively; p = 0.049) and recombinant human erythropoietin use (20 vs. 29 vs. 76%, respectively; p = 0.016). No significant differences in weekly total Kt/V (p = 0.704), weekly peritoneal Kt/V (p = 0.064) and residual glomerular filtration rate (p = 0.355) were found across the three groups. CONCLUSIONS: Delivered clearance measured by weekly peritoneal Kt/V and total clearance measured by weekly total Kt/V did not predict the response to hepatitis B virus vaccination in patients on peritoneal dialysis.
topic Continuous ambulatory peritoneal dialysis
Hepatitis B virus
Vaccination
Dialysis adequacy
Kt/V
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000900009
work_keys_str_mv AT erkandervisoglu antibodyresponsefollowinghepatitisbvaccinationinperitonealdialysispatientsdoesnormalizedureaclearancematter
AT melihsimsek antibodyresponsefollowinghepatitisbvaccinationinperitonealdialysispatientsdoesnormalizedureaclearancematter
AT ahmetyilmaz antibodyresponsefollowinghepatitisbvaccinationinperitonealdialysispatientsdoesnormalizedureaclearancematter
_version_ 1725228255691145216